Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-08-13

FDA Approved: PROPAFENONE HCL — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Propafenone hydrochloride (Propafenone HCl) from Actavis Pharma, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Propafenone HCl (propafenone hydrochloride)

Snippet

SUPPL AP for PROPAFENONE HCL (PROPAFENONE HYDROCHLORIDE)